Skip to content
Home
LIVE · CORPUS
Dossier

RA Capital Nexus Fund II, L.P.

Low
PersonUS
The finding

Controls or directs 24 companies in the resolved graph.

/01

Key facts

Risk signal
Controls
24 companies
Appears in
1 source
Risk
Low
Jurisdiction
US

RA Capital Nexus Fund II, L.P. controls or directs 24 companies (US), resolved across 1 source.

/02

Also appears in

GLEIF

The same real-world entity, resolved across sources.

/03

Control & directorships

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Controlled by

None in current sources.

Directorships & controlled companies
/04

Directorship network

700 other roles

Where this entity’s officers also hold (or held) positions — the wider network reached through shared people. Roles are registry records, not a claim of control.

Janux Therapeutics, Inc.
Acrivon Therapeutics, Inc.
PepGen Inc.
ARS Pharmaceuticals, Inc.
Climb Bio, Inc.
Acumen Pharmaceuticals, Inc.
LENZ Therapeutics, Inc.
Werewolf Therapeutics, Inc.
AN2 Therapeutics, Inc.
Boundless Bio, Inc.
ICOSAVAX, INC.
DICE MOLECULES HOLDINGS, LLC
Cytek Biosciences, Inc.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on RA Capital Nexus Fund II, L.P.. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnakeScore.

Sign in to contribute a tip and earn reputation — it's free.
Loading tips…